The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Immunogen
This antiserum was produced against synthesized non-phosphopeptide derived from human NF-B p100/p52 around the phosphorylation site of serine 869 (Y-G-SP-Q-S).
Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 50% glycerol
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
-20 °C
Faye: "Bioprospecting, genetic patenting and indigenous populations: challenges under a restructured information commons." in: The Journal of world intellectual property, Vol. 7, Issue 3, pp. 401-28, (2006) (PubMed).
Qu, Qing, Rabson, Xiao: "Tax deregulation of NF-kappaB2 p100 processing involves both beta-TrCP-dependent and -independent mechanisms." in: The Journal of biological chemistry, Vol. 279, Issue 43, pp. 44563-72, (2004) (PubMed).
Target
NFKB2
(Nuclear Factor of kappa Light Polypeptide Gene Enhancer in B-Cells 2 (NFKB2))